SPS
COGT icon

Susquehanna Portfolio Strategies’s Cogent Biosciences COGT Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.89M Hold
229,755
– – 0.14% 196
2026
Q1 		$8.84M Hold
229,755
– – 0.13% 205
2025
Q4 		$8.16M Hold
229,755
– – 0.13% 223
2025
Q3 		$3.3M Buy
229,755
+134,035
+140% +$1.59M 0.05% 390
2025
Q2 		$687K Buy
+95,720
New +$531K 0.02% 585

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Susquehanna Portfolio Strategies's COGT Position: Q2 2026 in Review

Susquehanna Portfolio Strategies held its Cogent Biosciences (COGT) position steady in Q2 2026 at 229,755 shares worth $8.89M. The position accounts for 0.14% of the portfolio, ranked #196.

Susquehanna Portfolio Strategies first reported a position in COGT in Q2 2025 and has held it in 5 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Susquehanna Portfolio Strategies held 229,755 shares of Cogent Biosciences worth $8.89M as of Q2 2026.
  • Susquehanna Portfolio Strategies left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up 0.14% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #196 holding.
  • Susquehanna Portfolio Strategies first reported a position in Cogent Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.